LBA2 ALINA: Efficacy and safety of adjuvant alectinib versus chemotherapy in patients with early-stage ALK+ non-small cell lung cancer (NSCLC) - Concepedia

Concepedia

Publication | Closed Access

LBA2 ALINA: Efficacy and safety of adjuvant alectinib versus chemotherapy in patients with early-stage ALK+ non-small cell lung cancer (NSCLC)

71

Citations

0

References

2023

Year

Benjamin Solomon, Jin Seok Ahn, Rafał Dziadziuszko, Fabrice Barlési, Makoto Nishio, Daniel Lee, Jin Sun Lee, W-Z. Zhong, Hidehito Horinouchi, Weimin Mao,

Annals of Oncology

OncologyPharmacologyImmune Checkpoint InhibitorCancer TreatmentLba2 AlinaMedicineLung Cancer

No additional data available for this publication yet. Check back later!